0001991732-26-000001.txt : 20260121 0001991732-26-000001.hdr.sgml : 20260121 20260121114820 ACCESSION NUMBER: 0001991732-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260121 DATE AS OF CHANGE: 20260121 EFFECTIVENESS DATE: 20260121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cantai Therapeutics, Inc. CENTRAL INDEX KEY: 0001991732 ORGANIZATION NAME: EIN: 933026358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-570571 FILM NUMBER: 26545517 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPIA STATE: PA ZIP: 19104 BUSINESS PHONE: 603-996-1218 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001991732 Cantai Therapeutics, Inc. 3675 MARKET STREET SUITE 200 PHILADELPIA PA PENNSYLVANIA 19104 603-996-1218 DELAWARE None None Corporation true 2023 Ross Leimberg 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Errik B. Anderson 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Getta Vemuri 3675 Market Street, Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-01-15 false true false 0 3000000 3000000 0 false 3 0 0 0 true false Cantai Therapeutics, Inc. Ross Leimberg Ross Leimberg Chief Operating Officer 2026-01-21